80TiP Global phase III study of NUC-1031 plus cisplatin vs gemcitabine plus cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).
Saved in:
| Title: | 80TiP Global phase III study of NUC-1031 plus cisplatin vs gemcitabine plus cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121). |
|---|---|
| Authors: | Knox, J.J.1 (AUTHOR), McNamara, M.G.2 (AUTHOR), Goyal, L.3 (AUTHOR), Doherty, M.4 (AUTHOR), Cosgrove, D.5 (AUTHOR), Springfeld, C.6 (AUTHOR), Sjoquist, K.7 (AUTHOR), Park, J.O.8 (AUTHOR), Verdaguer, H.9 (AUTHOR), Braconi, C.10 (AUTHOR), Ross, P.11 (AUTHOR), De Gramont, A.12 (AUTHOR), Zalcberg, J.R.13 (AUTHOR), Palmer, D.14 (AUTHOR), Valle, J.W.2 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS272-S273. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
